Two Recombinant Bacteriocins, Rhamnosin and Lysostaphin, Show Synergistic Anticancer Activity Against Gemcitabine-Resistant Cholangiocarcinoma Cell Lines
Cholangiocarcinoma (CCA), a bile duct cancer with a high mortality rate, has a poor prognosis due to its highly invasive and drug-resistant phenotypes. More effective and selective therapies are urgently needed. Bacteriocins are broad-spectrum antimicrobial peptides/proteins produced by bacterial st...
Saved in:
Main Author: | Kerdkumthong K. |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/84830 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Gemcitabine enhances cytotoxic activity of effector T-lymphocytes against chemo-resistant cholangiocarcinoma cells
by: Nunghathai Sawasdee, et al.
Published: (2020) -
Gemcitabine enhances cytotoxic activity of effector T-lymphocytes against chemo-resistant cholangiocarcinoma cells
by: Nunghathai Sawasdee, et al.
Published: (2020) -
Lysostaphin: An antistaphylococcal agent
by: Kumar, J.K.
Published: (2011) -
Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines
by: Bundit Promraksa, et al.
Published: (2020) -
Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma
by: Chalyut Charoentum, et al.
Published: (2018)